Evidence map›Paper›PMID 23314823›Full record

ArticleJournal of neuro-oncology2013

Role of surgery, radiotherapy and chemotherapy in papillary tumors of the pineal region: a multicenter study.

F Fauchon, M Hasselblatt, A Jouvet, J Champier, M Popovic, R Kirollos, T Santarius, S Amemiya, T Kumabe, D Frappaz and 3 more

Abstract readMulticenter Study
PubMed Publisher
In one paragraph

Article in Journal of neuro-oncology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 1 pooled it
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 1 synthesis or guideline pooled it, 73 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Decisional Tree for Pineal Tumors.Advances and technical standards in neurosurgery · 2026
    Review
  6. Pineal Tumors and Pineal Region Tumors.Advances and technical standards in neurosurgery · 2026
    Review
  7. Histopathology and Molecular Pathology of Pineal Region Tumors.Advances and technical standards in neurosurgery · 2026
    Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Histopathology and molecular pathology of pediatric pineal parenchymal tumors.Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery · 2023
    Review
  14. Benign and Malignant Tumors of the Pineal Region.Advances in experimental medicine and biology · 2023
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 11 institutions in 5 countries.

F FauchonCentre de Haute Energie, Centre de Radiothérapie Privé and ADeRTU, Nice, France.
M Hasselblatt
A Jouvet
J Champier
M Popovic
R Kirollos
T Santarius
S Amemiya
T Kumabe
D Frappaz
M Lonjon
M Fèvre Montange
A Vasiljevic
Addenbrooke's Hospital · GBCentre de Haute Energie · FRCentre de Recherche en Neurosciences de Lyon · FRCentre Léon Bérard · FRCentre National de la Recherche Scientifique · FRHôpital Pasteur · FRInserm · FRThe University of Tokyo · JPTohoku University · JPUniversity Hospital Münster · DEUniversity of Ljubljana · SI

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Papillary tumor of the pineal region (PTPR), recently described as a distinct clinicopathological entity, can show aggressive biological behavior. The optimal therapeutic approach of PTPR has not been well defined. The role of surgery, radiotherapy, and chemotherapy in the treatment of PTPR was analyzed in a large multicenter series. In order to determine factors that influence prognosis, outcome data of a series of 44 patients with histopathologically proven PTPR were retrospectively analyzed. Of the 44 patients, 32 were still alive after a median follow-up of 63.1 months. Twelve patients experienced progressive disease, with seven undergoing two relapses and five more than two. Median overall survival (OS) was not achieved. Median progression-free survival (PFS) was 58.1 months. Only gross total resection and younger age were associated with a longer OS, radiotherapy and chemotherapy having no significant impact. PFS was not influenced by gross total resection. Radiotherapy and chemotherapy had no significant effect. This retrospective series confirms the high risk of recurrence in PTPR and emphasizes the importance of gross total resection. However, our data provide no evidence for a role of adjuvant radiotherapy or chemotherapy in the treatment of PTPR.

Indexed as

AdolescentAdultAgedAntineoplastic Combined Chemotherapy ProtocolsCarcinoma, PapillaryChildChild, PreschoolCombined Modality TherapyDisease ProgressionFemaleFollow-Up StudiesHumansMaleMiddle AgedNeoplasm Recurrence, LocalNeoplasm Staging

Identifiers

PMID23314823
OpenAlexW1966802842

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.